Direct answer: Remove legacy transition assumptions from Canadian product records.
Record the current regulatory edition
Tag every classification, label and SDS with its reviewed HPR basis and source date.
Close transition-era exceptions
Portfolio records that merely noted a future migration now require a completion decision and evidence.
Review source data before templates
Changed classes and information elements may require new inputs; changing headings alone is not a migration.
Assess labels and SDSs together
The same amended classification record should support both outputs.
Archive the migration decision
Preserve the prior basis, changed values, reviewer and release date for each product.
Practical example
A portfolio still marks aerosol records as ‘transition pending.’ The team identifies affected products, confirms current classification inputs, regenerates bilingual labels and SDSs, and records approval.
Release checklist
- Find legacy HPR records
- Confirm amended-HPR source
- Review affected hazard classes
- Update both languages and labels
- Approve and archive migration
Common mistakes
- Using an expired transition plan
- Updating only the revision date
- Assuming US implementation dates apply in Canada
Frequently asked questions
When did the amendments take effect?
Health Canada states December 15, 2022.
When did transition end?
Health Canada states the three-year period ended December 14, 2025.
Can old output be newly released now?
Current releases should be assessed against the amended HPR and current official guidance.
Should dates be hard-coded?
Maintain them as sourced regulatory records with review dates.
Primary sources
- Health Canada · Amended Hazardous Products Regulations
- Health Canada · End of the HPR transition period
- Hazardous Products Regulations (current consolidation)
Review notice: CANADIAN REGULATORY AND FRENCH TERMINOLOGY REVIEW REQUIRED BEFORE INDEXING.